TrialScientific reports2025

An open-label, randomized study comparing lipegfilgrastim with filgrastim in pediatric patients receiving chemotherapy for Ewing sarcoma or rhabdomyosarcoma.

Margarita B Belogurova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.